Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2

N Engl J Med. 2022 Apr 14;386(15):1475-1477. doi: 10.1056/NEJMc2201933. Epub 2022 Mar 9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents* / pharmacology
  • Antiviral Agents* / therapeutic use
  • COVID-19 Drug Treatment*
  • Humans
  • SARS-CoV-2* / drug effects
  • Spike Glycoprotein, Coronavirus

Substances

  • Antiviral Agents
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2

Supplementary concepts

  • SARS-CoV-2 variants